切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2017, Vol. 06 ›› Issue (06) : 241 -245. doi: 10.3877/cma.j.issn.2095-3216.2017.06.001

所属专题: 文献

述评

加强对急性肾脏病的认识与管理
孙林1,(), 刘伏友1, 陈香美2   
  1. 1. 410011 长沙,中南大学肾脏病研究所、湘雅二医院肾内科
    2. 100853 北京,解放军总医院肾脏病科、解放军肾脏病研究所、肾脏疾病国家重点实验室、国家慢性肾病临床医学研究中心
  • 收稿日期:2017-10-13 出版日期:2017-12-28
  • 通信作者: 孙林
  • 基金资助:
    国家自然科学基金重点(81730018); 国家重大基础研发计划(2016YFC1305501); 国家自然科学基金面上(81470960)

Acute kidney disease: raising awareness and improving management of the course

Lin Sun1,(), Fuyou Liu1, Xiangmei Chen2   

  1. 1. Department of Nephrology, Second Xiangya Hospital, Central South University Institute of Nephrology, Changsha 410011, Hunan Province, China
    2. Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Chronic Kidney Diseases, Beijing 100853, China
  • Received:2017-10-13 Published:2017-12-28
  • Corresponding author: Lin Sun
  • About author:
    Corresponding author: Sun Lin, Email:
引用本文:

孙林, 刘伏友, 陈香美. 加强对急性肾脏病的认识与管理[J/OL]. 中华肾病研究电子杂志, 2017, 06(06): 241-245.

Lin Sun, Fuyou Liu, Xiangmei Chen. Acute kidney disease: raising awareness and improving management of the course[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2017, 06(06): 241-245.

急性肾损伤(AKI)是一种严重危害人类健康与生命安全的重大疾病,AKI发生后部分患者可转为慢性肾脏病(CKD)。近期美国急性疾病质量倡议(ADQI)专家共识正式将AKI发生后7 d至进入CKD(90 d)前这一特殊时间窗的疾病状态命名为急性肾脏病(AKD)。目前认为AKD是AKI发生后肾脏恢复和减少持续损伤的关键干预点。鉴于AKD概念较新,临床医师认识尚不足,为此我们邀请了国内知名的肾脏病专家对AKD流行病学、发病机制、临床表现、诊断与治疗等问题进行初步介绍,以加强对AKD的认识与管理,提高AKD防治水平,开辟临床肾脏病学新领域。

Acute kidney injury (AKI) is a type of severe illness that seriously endangers human health and life, and may be converted to chronic kidney disease (CKD) in some patients. Recently, Acute Disease Quality Initiative (ADQI) expert consensus formally named the disease course, from after 7 days of AKI to the onset of CKD for 90 days, as acute kidney disease (AKD). At present, AKD is regarded as a key point of intervention for promoting recovery and reducing persistent damage after AKI occurrence. In view of the newer concept of AKD, clinicians are not yet fully aware of it. Therefore, we invited well-known domestic nephrologists to introduce the epidemiology, pathogenesis, clinical manifestations, diagnosis and treatment of AKD so as to enhance the awareness and management of AKD, improve the level of prevention and treatment of AKD, and open up new areas for clinical nephrology.

1
Rossaint J, Zarbock A. Acute kidney injury: definition, diagnosis and epidemiology[J]. Minerva Urol Nefrol, 2016, 68(1): 49-57.
2
Chawla LS, Rinaldo B, Azra B, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Work Group [J]. Nat Rev Nephrol, 2017, 13(4): 241-257.
3
Silver SA, Chertow GM. The economic consequences of acute kidney injury [J]. Nephron, 2017, [Epub ahead of print].
4
Mehta RL, Cerdá J, Burdmann EA, et al. International Society of Nephrology′s Oby25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology [J]. Lancet, 2015, 385(9987): 2616-2643.
5
Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis [J]. Clin J Am Soc Nephrol, 2013, 8(9): 1482-1493.
6
Chawla LS, Eggers PW, Star RA, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes [J]. N Engl J Med, 2014, 371(1): 58-66.
7
Sawhney S, Fraser SD. Epidemiology of AKI: utilizing large databases to determine the burden of AKI[J]. Adv Chronic Kidney Dis, 2017, 24(4): 194-204.
8
Mizuno T, Sato W, Ishikawa K, et al. KDIGO (Kidney Disease: Improving Global Outcomes) criteria could be a useful outcome predictor of cisplatin-induced acute kidney injury [J]. Oncology, 2012, 82(6): 354-359.
9
Ferenbach DA, Bonventre JV. Acute kidney injury and chronic kidney disease: From the laboratory to the clinic [J]. Nephrol Ther, 2016, 12(Suppl 1): S41-S48.
10
He L, Sun L, Peng Y, et al. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms [J]. Kidney Int, 2017, 92(5): 1071-1083.
11
Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome [J]. Kidney Int, 2012, 82(5): 516-524.
12
Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis [J]. Kidney Int, 2012, 81(5): 442-448.
13
付平,刘菁,曾筱茜. 急性肾脏病的诊断和临床意义及现状思考[J/CD].中华肾病研究电子杂志,2017,6(6):259-265.
14
Lewington AJ, Cerda J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer [J]. Kidney Int, 2013, 84(3): 457-467.
15
Odutayo A, Wong CX, Farkouh M, et al. AKI and long-term risk for cardiovascular events and mortality[J]. J Am Soc Nephrol, 2017, 28(1): 377-387.
16
Villeneuve PM, Clark EG, Sikora L, et al. Health-related quality-of-life among survivors of acute kidney injury in the intensive care unit: a systematic review [J]. Intensive Care Med, 2016, 42(2): 137-146.
17
Faubel S, Chawla LS, Chertow GM, et al. Ongoing clinical trials in AKI [J]. Clin J Am Soc Nephrol, 2012, 7(5): 861-873.
18
Hsu CY. Yes, AKI truly leads to CKD [J]. J Am Soc Nephrol, 2012, 23(6): 967-969.
19
Sawhney S, Marks A, Fluck N, et al. Intermediate and long-term outcomes of survivors of acute kidney injury episodes: a large population-based cohort study [J]. Am J Kidney Dis, 2017, 69(1): 18-28.
20
Silver SA, Siew ED. Follow-up care in acute kidney injury: lost in transition [J]. Adv Chronic Kidney Dis, 2017, 24(4): 246-252.
21
肖力,孙林,刘伏友. 急性肾脏病的病因及发病机制[J/CD].中华肾病研究电子杂志,2017,6(6): 252-258.
22
Tanaka S, Tanaka T, Nangaku M. Hypoxia as a key player in the AKI-to-CKD transition [J]. Am J Physiol Renal Physiol, 2014, 307(11): 1187-1195.
23
Nangaku M, Hirakawa Y, Mimura I, et al. Epigenetic changes in the acute kidney injury-to-chronic kidney disease transition [J]. Nephron, 2017, [Epub ahead of print].
24
Canaud G, Bonventre JV. Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury [J]. Nephrol Dial Transplant, 2015, 30(4): 575-83.
25
Xiao L, Zhou D, Tan RJ, et al. Sustained activation of Wnt/beta-catenin signaling drives AKI to CKD progression [J]. J Am Soc Nephrol, 2016, 27(6): 1727-1740.
26
Renhua L, Miaolin C, Junlin W, et al. The level of the biomarkers at the time of nephrology consultation might predict the prognosis of acute kidney injury in hospitalized patients [J]. Blood Purif, 2014, 38(2): 89-95.
27
Hu Y, Liu H, Du L, et al. Serum cystatin C predicts AKI and the prognosis of patients in coronary care unit: a prospective, observational study [J]. Kidney Blood Press Res, 2017, 42(6): 961-973.
28
Tan HL, Yap JQ, Qian Q. Acute kidney injury: tubular markers and risk for chronic kidney disease and end-stage kidney failure [J]. Blood Purif, 2016, 41(1-3): 144-1150.
29
Ronco C, Chawla LS. Glomerular and tubular kidney stress test: new tools for a deeper evaluation of kidney function [J]. Nephron, 2016, 134(3): 191-194.
30
Ninet S, Schnell D, Dewitte A, et al. Doppler-based renal resistive index for prediction of renal dysfunction reversibility: a systematic review and meta-analysis [J]. J Crit Care, 2015, 30(3): 629-635.
31
Yang L, Xing G, Wang L, et al. Acute kidney injury in China: a cross-sectional survey [J]. Lancet, 2015, 386(10002): 1465-1471.
32
郭志勇,边琪.急性肾脏病的治疗与预防[J/CD].中华肾病研究电子杂志,2017,6(6): 266-270.
33
Kojima I, Tanaka T, Inagi R, et al. Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney [J]. J Am Soc Nephrol, 2007, 18(4): 1218-1226.
34
Basile DP, Bonventre JV, Mehta R, et al. Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments [J]. J Am Soc Nephrol, 2016, 27(3): 687-697.
35
Harel Z, Wald R, Bargman JM, et al. Nephrolgist follow-up improves all-cause mortality of severe acute kidney injury survivors [J]. Kidney Int, 2013, 83(5): 901-908.
36
Silver SA, Harel Z, Harvey A, et al. Improving care after acute kidney injury: a prospective time series study [J]. Nephron, 2015, 131(1): 43-50.
37
Silver SA, Goldstein SL, Harel Z, et al. Ambulatory care after acute kidney injury: an opportunity to improve patient outcomes [J]. Can J Kidney Health Dis, 2015, 2(1): 36.
38
姜娜,孙林.2017年ADQI急性肾脏病和肾脏恢复的专家共识解读[J/CD].中华肾病研究电子杂志,2017,6(6): 278-281.
39
Chen J, Kong X, Jia X, et al. Association between metabolic syndrome and chronic kidney disease in a Chinese urban population [J]. Clin Chim Acta, 2017, 470: 103-108.
40
Khalil AA, Abed MA, Ahmad M, et al. Under-diagnosed chronic kidney disease in Jordanian adults: prevalence and correlates [J]. J Ren Care, 2018, 44(1): 12-18.
41
Ko YA, Yi H, Qiu C, et al. Genetic-variation-driven gene-expression changes highlight genes with important functions for kidney disease [J]. Am J Hum Genet, 2017, 100(6): 940-953.
42
Nie S, Feng Z, Tang L, et al. Risk factor analysis for AKI including laboratory indicators: a nationwide multicenter study of hospitalized patients [J]. Kidney Blood Press Res, 2017, 42(5): 761-773.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[7] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[8] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[9] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要